BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 12, 2025
See today's BioWorld MedTech
Home
» Avenda Health’s AI tech identifies prostate cancer with 84% accuracy
To read the full story,
subscribe
or
sign in
.
Avenda Health’s AI tech identifies prostate cancer with 84% accuracy
June 13, 2024
By
Holland Johnson
Avenda Health Inc. said the findings of a new study published in
The Journal of Urology
demonstrate the ability of artificial intelligence to accurately identify cancer in oncology imaging and diagnostics.
BioWorld MedTech
Clinical
Artificial intelligence
Cancer
Oncology
Urology
U.S.